Miller Mary 4

What Happened Mary Miller, Chief Legal Officer of Acrivon Therapeutics (ACRV), had 659 shares of ACRV withheld to satisfy mandatory tax withholding tied to the vesting of restricted stock units. The withholding was recorded at $1.98 per share for a total value of $1,305. This was a tax-withholding disposition of vested RSUs, not an open-market sale or purchase.

Key Details

• Transaction date: 2026-01-17
• Price used for withholding: $1.98 per share
• Shares withheld/disposed: 659 (total value $1,305)
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: F1 — shares were withheld by the issuer to satisfy mandatory tax withholding upon RSU vesting
• Filing: Report filed 2026-01-21 (4 days after the transaction date); this appears later than the usual two-business-day Form 4 filing requirement

Context This transaction is a routine tax-withholding action following RSU vesting and does not reflect an attempted market sale or an insider purchase. Such withholdings are common and generally do not indicate the insider's market view.